Header cover image

German (DAX) Biotech Industry Analysis

UpdatedJul 17, 2024
DataAggregated Company Financials
Companies11
  • 7D-2.4%
  • 3M3.9%
  • 1Y-16.5%
  • YTD-11.5%

Over the last 7 days, the Biotech industry has dropped 2.4%, driven by MorphoSys declining 0.4%. However, the industry is down 16% over the past year. As for the next few years, earnings are forecast to decline by 36% per annum.

Industry Valuation and Performance

Has the German Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 17 Jul 2024€2.7b€885.2m€215.0m12.6x12.6x3.1x
Fri, 14 Jun 2024€2.6b€884.7m€210.7m11.3x12.4x3x
Sun, 12 May 2024€2.6b€884.7m€210.7m10x12.1x2.9x
Tue, 09 Apr 2024€2.7b€773.3m€10.4m9.2x257.8x3.5x
Thu, 07 Mar 2024€2.6b€747.5m-€56,329,307.2012.1x-46.6x3.5x
Sat, 03 Feb 2024€2.7b€769.9m-€145,885,802.0013.1x-18.7x3.5x
Mon, 01 Jan 2024€2.9b€769.9m-€145,885,802.0013.5x-19.7x3.7x
Wed, 29 Nov 2023€2.9b€779.7m-€160,010,802.0013.8x-18.4x3.8x
Fri, 27 Oct 2023€3.7b€955.3m-€172,995,145.0011.1x-21.7x3.9x
Sun, 24 Sep 2023€3.9b€971.6m-€197,588,171.0011x-19.8x4x
Tue, 22 Aug 2023€4.0b€947.8m-€36,633,772.0018.8x-109.4x4.2x
Thu, 20 Jul 2023€4.2b€955.7m-€219,213,323.0028.3x-19.2x4.4x
Sat, 17 Jun 2023€4.2b€967.4m-€212,883,319.0030x-19.7x4.3x
Mon, 15 May 2023€3.9b€967.4m-€209,726,026.0035x-18.6x4x
Wed, 12 Apr 2023€3.6b€920.1m-€215,271,987.0013.8x-16.7x3.9x
Fri, 10 Mar 2023€2.9b€612.1m-€74,393,227.0010.3x-39.3x4.8x
Sun, 05 Feb 2023€3.0b€612.1m-€74,509,505.0010.9x-40.6x4.9x
Tue, 03 Jan 2023€3.0b€611.9m-€53,407,435.0011.3x-57.1x5x
Thu, 01 Dec 2022€3.0b€611.9m-€53,407,435.0011.1x-56.7x4.9x
Sat, 29 Oct 2022€2.6b€627.4m-€129,805,157.005.8x-19.8x4.1x
Mon, 26 Sep 2022€2.5b€627.4m-€129,805,157.005.1x-19.6x4.1x
Wed, 24 Aug 2022€2.8b€605.7m-€150,021,513.006.4x-18.4x4.5x
Fri, 22 Jul 2022€3.4b€772.0m-€724,268,362.00n/a-4.7x4.5x
Sun, 19 Jun 2022€3.3b€768.8m-€724,082,241.00n/a-4.5x4.3x
Tue, 17 May 2022€3.2b€769.9m-€725,319,944.00n/a-4.4x4.2x
Thu, 14 Apr 2022€3.8b€808.9m-€704,269,813.00n/a-5.3x4.6x
Sat, 12 Mar 2022€3.4b€789.6m-€311,283,353.00n/a-11x4.4x
Mon, 07 Feb 2022€3.7b€789.6m-€311,283,353.00n/a-11.9x4.7x
Wed, 05 Jan 2022€4.0b€789.6m-€311,283,353.00n/a-12.8x5.1x
Fri, 03 Dec 2021€4.1b€789.6m-€311,690,565.00n/a-13.1x5.2x
Sun, 31 Oct 2021€4.5b€771.2m-€257,628,521.00n/a-17.3x5.8x
Tue, 28 Sep 2021€4.2b€767.7m-€220,638,446.00n/a-19.3x5.5x
Thu, 26 Aug 2021€4.3b€769.4m-€175,243,228.001.4x-24.5x5.6x
Price to Earnings Ratio

-24.2x


Total Market Cap: €4.2bTotal Earnings: -€175,243,228.00Total Revenue: €769.4mTotal Market Cap vs Earnings and Revenue0%0%0%
German Biotech Industry Price to Earnings3Y Average -18.4x202220232024
Current Industry PE
  • Investors are pessimistic on the German Biotechs industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 12.6x which is higher than its 3-year average PE of -18.4x.
  • The 3-year average PS ratio of 4.4x is higher than the industry's current PS ratio of 3.1x.
Past Earnings Growth
  • Total earnings for the Biotechs industry have gone up over the last three years, and the industry is now profitable. Revenues have grown 4.8% per year.
  • This means that more sales are being generated by the industry overall, and subsequently profits are increasing too.

Industry Trends

Which industries have driven the changes within the German Healthcare industry?

DE Market1.24%
Healthcare2.01%
Biotech-2.41%
Biotech-2.41%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
VSC 4SC€4.763.5%
+€1.6m
-55.1%PS158.4x
MDG1 Medigene€1.184.0%
+€1.3m
-39.8%PS5.8x
CNW co.don€0.01131.3%
+€66.8k
-72.4%n/a
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

MOR

€67.75

MorphoSys

7D

-0.4%

1Y

128.3%

HPHA

€2.59

Heidelberg Pharma

7D

-0.4%

1Y

-27.9%

MDG1

€1.18

Medigene

7D

4.0%

1Y

-39.8%

FYB

€53.90

Formycon

7D

-0.7%

1Y

-9.4%

T9G

€0.27

Vidac Pharma Holding

7D

-15.6%

1Y

-81.6%

ECX

€0.60

Epigenomics

7D

-2.0%

1Y

-82.3%

PA8K

€0.022

Paion

7D

-8.3%

1Y

-99.6%

20B

€0.12

Biomark Diagnostics

7D

-8.1%

1Y

-27.5%

CNW

€0.011

co.don

7D

31.3%

1Y

-72.4%